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Abstract  
BACKGROUND: Factors predictive of growth retardation and malnutrition in patients with 
congenital heart disease remain unclear. 
OBJECTIVES: This study aimed to measure antibody response to bovine casein through 
assessing serum casein antibody levels in malnourished patients three year or younger with CHD, 
and to determine its relationship to gastrointestinal symptoms, anthropometric measures, and 
laboratory data. 
SUBJECTS AND METHODS: This cross sectional case control study was conducted in sixty 
patients with CHD aged 4 to 72 months. They were subdivided into thirty patients with cyanotic and 
thirty patients with acyanotic CHD compared with thirty apparently healthy children. 
RESULTS: On comparison with controls, patients showed highly significant lower anthropometric 
measures, calcium, iron, hemoglobin levels, and higher serum levels of casein antibody, total iron 
binding capacity, and alkaline phoshatase activity (P<0.000). Serum levels of casein antibody 
showed significantly positive correlations with serum total iron binding capacity and alkaline 
phosphatase activities and negatively correlated with the age at onset of symptoms, anthropometric 
measures, serum calcium, and iron levels. 
CONCLUSION: Serum casein antibody levels play a significant role in the pathogenesis of 
malnutrition. Encouragement of breast feeding and avoidance of early cow's milk consumption 
could prevent the development of antibody response to bovine casein. 
 
 
 
 
Introduction 
 
Congenital heart disease (CHD) is the most 
common congenital malformation which occurs in 
0.8% of all live births [1]. Infants with congenital heart 
disease (CHD) are prone to malnutrition for several 
reasons including associated chromosomal 
anomalies/genetic syndromes [2], inadequate 
nutritional intake due to feeding difficulties, elevated 
energy expenditure and poor absorption of nutrients 
from the digestive tract in chronic congestive heart 
failure (CHF) [3]. There is loss of body mass which 
affects heart, respiratory muscles, compromising the 
myocardial and ventilatory functions, healing capacity, 
and immunological competency with consequent 
increased risk of infection [4]. Such malnutrition 
ranges from mild under-nutrition to failure to thrive. 
This can have a notable effect on the outcome of 
surgery, increasing morbidity and mortality [5].  
Cow’s milk protein allergy (CMPA) affects 
from 2 to 7.5% of children in the first years of the life 
[6]. About 50% of children have been shown to 
resolve CMPA within the first year of age, 80-90% 
within their fifth year. However, in a small minority of 
patients, cow’s milk allergy may be lifelong and severe 
[7]. Cow's milk protein allergy results from an 
immunological reaction to one or more milk proteins. 
Immunological mechanisms leading to this food 
allergy include immunoglobin E and cellular immune 
response. The proteins most frequently and most 
intensively recognized by specific IgE are casein and 
lactoglobulin. All milk proteins appear to be potential 
allergens, even those that are present in milk in trace 
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amounts [8].  
The onset of cow’s milk protein allergy is 
closely related to the introduction of cow’s milk based 
infant formulas into the diet. An infant can experience 
symptoms either very quickly after feeding (rapid 
onset) or up to several days or even weeks after first 
consuming the cow's milk protein (slower onset). The 
most common symptoms are gastrointestinal (50-
60%), cutaneous eczema (50-60%), and respiratory 
(20-30%). Many infants may experience two or more 
of these symptoms [6, 9]. Late reactions due to cow’s 
milk allergy are atopic dermatitis, gastroesophageal 
reflux disease, eosinophilic esophago-
gastroenteropathy, protein-losing enteropathy with 
hypo-albuminemia, enterocolitis, chronic diarrhea, 
blood in the stools, iron deficiency anemia, chronic 
vomiting, colic, poor growth with subsequent 
malnutrition. The reaction can stop at any stage or 
may develop into anaphylaxis (a serious allergic 
reaction that affects several body organs). In severe 
cases, an allergic reaction to milk can develop after 
tiny amounts of milk [10].   
An accurate diagnosis of CMPA is important 
in order to avoid not only the risk of rickets, decreased 
bone mineralization, anemia, poor growth and 
hypoalbuminemia, but also that of immediate clinical 
reactions or severe chronic gastroenteropathy leading 
to malabsorption. Strict avoidance of all traces of milk 
and all dairy products is the only way to deal with this 
type of allergy [11]. Therefore, this study aimed to 
measure antibody response to bovine casein through 
assessing serum levels of casein antibody, and 
evaluates its relationship with type of the cardiac 
lesions, the nutritional status, the anthropometric 
measures, gastrointestinal symptoms, hematological, 
and biochemical data and to determine the predictors 
of high serum casein antibody level among Egyptian 
malnourished infants and young children with 
congenital heart disease.  
 
 
Subjects and Methods 
      
Subjects 
            This cross sectional case control study was 
conducted on 60 CHD patients (36 girls, and 24 boys) 
who were attending the Nutrition Clinic of the NRC for 
nutritional management of malnourished children with 
CHD over a period of one year. They were referred 
from the Outpatient Pediatric Cardiology Clinics of the 
National Cardiac Institute, Egypt, during their regular 
follow up. The inclusion criteria for selection included 
malnourished infants and young children aged 4 to 72 
months with uncorrected symptomatic congenital 
cardiac defects. The exclusion criteria included 
children with palliated or corrected CHD, those with 
confirmed or suspected genetic syndromes, 
hospitalized, and asymptomatic CHD. Congenital 
cardiac defects were diagnosed by two-dimensional 
echocardiography. They were subdivided into two 
subgroups; 30 patients with cyanotic CHD (subgroup 
I), and 30 patients with acyanotic CHD (subgroup II). 
Their ages ranged from four to seventy two months, 
with a mean age of 20.72±19.68 months and a female 
to male ratio of 1.5:1.  
Age, sex and social class matched thirty 
apparently healthy children without CHD were 
included as the control group. They were selected 
from the outpatients' Clinic at National Research 
Center while they were coming for follow up. Written 
informed consent was obtained from the parents of 
the participating patients and controls.  
 
 
Methods 
 
Patients and controls were subjected to both 
nutritional assessment and the laboratory 
investigations which were done in the National 
Research Center. All the patients under study were 
subjected to detailed history taking including onset of 
cyanosis, tachypnea, tachycardia, shortness of 
breath, feeding difficulties, poor weight gain, repeated 
chest infections, congestive heart failure, previous 
hospitalizations, maternal drug intake during 
pregnancy, family history, positive consanguinity, birth 
weight, and nutritional history (duration of 
breastfeeding, age at weaning, weaning diet, quality 
and quantity of nutrients ingested during weaning 
period and at the time of the examinations). All 
studied infants and children were subjected to 
comprehensive physical examination, 
echocardiographic assessment with Hewlett Packard 
SONOS 5500 and standard telecardiography 
examination for the measurement of cardio-thoracic 
ratio (CTR). The modified Ross score was used to 
diagnose and grade heart failure severity in patients 
with CHD into three groups: no heart failure (score 0–
2), mild heart failure (score 3–6) and moderate to 
severe heart failure (score 7–12) [12]. 
Anthropometric measures were performed 
according to standard WHO procedures [13]. They 
included measurement of body weight, recumbent 
length or height, body mass index (BMI), occipito-
frontal, mid-arm, and mid chest circumferences. The 
body weight was determined to the nearest 0.1 kg on 
a seca scale balance with the subject dressed 
minimum clothes and no shoes. Heights or recumbent 
length (for children <2 years of age) were measured 
using a portable Leicester Height Measure (Seca) and 
Seca mechanical infantometer, respectively. The mid-
upper arms, mid-chest and occipito-frontal 
circumferences were measured with a Seca 200 
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measuring tape using standard procedures. Each 
measurement was taken as the mean of three 
consecutive readings as recommended by the 
International Biological program. Cases with 
anthropometric measurements under 5th percentile 
were evaluated to have malnutrition. The WHO 
recommends the use of standard definitions and 
classifications for malnutrition (under-nutrition) based 
on calculated z-scores for anthropometric indices [14, 
15]. Z-scores for weight for age (WAZ), weight for 
height (WHZ) and height for age (HAZ) are computed 
using Anthro-Program of Personal Computers 
(Atlanta, Georgia, USA), 2009 anthropometry program 
reference value (based on WHO reference median 
values). The WHO global database on child growth 
and malnutrition (under-nutrition) recommends a cut-
off z score of ≤−2 SD to classify low WAZ 
(underweight), low HAZ (stunting) and low WHZ 
(wasting) as moderate malnutrition, and a z-score of 
≤−3 SD to define severe malnutrition. Normal nutrition 
is indicated by a WAZ of between >−2 and ≤2 SD. 
From all cases, and controls 5 cc venous 
blood samples were obtained for laboratory assays, 
which were performed in the National Research 
Center, Egypt. Serum human casein IgE antibody 
level was measured using an enzyme-linked 
immunosorbent assay (ELISA) kit (Glory science, 
USA) according to the method described by 
Greenberg [16]. Cutoff values <200 ug/mL was 
considered to be normal.  
Serum calcium concentration was assayed by 
colorimetric method using kit purchased from Croma 
test Linear Chemicals Co., Spain, according to the 
method described by
 
Tietz [17]. Samples for assaying 
serum alkaline phosphatase activity (ALP) were kept 
at room temperature and assayed according to the 
manufacturer’s guidelines [18].  
Hemoglobin level was measured using a 
HemoCue B-Hemoglobin Photometer (HemoCue, 
ngelholm, Sweden). Anemia was defined as a 
hemoglobin level ≤10 g/dl for all controls. For children 
with cyanotic CHD, a hemoglobin level ≤15 g/dl, and 
MCV< 80 fl/ red cell were considered to indicate 
anemia, while anemia in acyanotic congenital heart 
disease was defined by hemoglobin level <12 g/dl, 
mean corpuscular volume (MCV) < 80 fl/ red cell 
based on a consensus of local experts [19].  
Serum iron and total iron binding capacity 
were measured according to the method described by
 
Perrotta and Kaplan [20] using a commercial kit 
(Reactivos GPL, Barceona, Spain, SU022). 
 
Statistical analysis 
Data were analyzed using Statistical Package 
for the Social Sciences (SPSS) version 21 computer 
program, and the results were presented as tables. 
Data were presented as means ± standard deviations, 
number and percentage (frequency distributions). Chi-
square (2) test was used for comparison between 
categorial data. The independent sample Student's t-
test was used for comparison between numerical 
data. ANOVA test was used for analysis of more than 
two groups followed by post hoc test if significant. 
Correlations between various variables were done 
using Pearson correlation. Univariate analysis of each 
covariate (item by item) was performed to identify 
significant predictors of high serum levels of casein 
antibody in patients. Odds ratio was calculated as a 
measure of association between the different risk 
factors and congenital heart diseases at 95% 
confidence limit. Multiple regression analysis was 
performed to examine the relationship between serum 
casein antibody level and anthropometric measures, 
hemoglobin level and serum alkaline phosphatase 
activity. A p value of less than 0.05 was considered 
statistically significant and p-value of less than 0.005 
was considered statistically highly significant 
throughout all statistical tests. 
 
 
Results  
 
A total of 60 patients with CHD aged between 
4-72 months (mean 20.72± 19.68 months) were 
studied. According to two-dimensional 
echocardiography, the patients were subdivided into 
two subgroups; 30 patients with cyanotic CHD 
(subgroup I), and 30 patients with acyanotic CHD 
(subgroup II). They were 24 girls (60%) and 16 boys 
(40%) with female to male ratio 1.5:1.  Ventricular 
septal defect (VSD) and patent ductus arteriosus 
(PDA) were the leading acyanotic cardiac lesions 
(20%). Combined ventricular septal defect (VSD) and 
patent ductus arteriosus (PDA) were present in (5 %), 
and A -V canal was present in (5 %). Tetralogy of 
Fallot (TOF) was the most frequent cyanotic lesion 
(20%). Transposition of the great arteries was present 
in (10%) patients, and combined D- TGA, VSD, and 
pulmonary stenosis (PS) were present in (10%), 
pulmonary atresia, and ventricular septal defect (VSD) 
in (5%), while combined DORV and malposed great 
vessels were present in (10%). Table 1 shows 
distribution of cardiovascular malformations in all 
studied patients.     
 
Table 1: Distribution of cardiovascular malformations in 
studied patients (n=60).  
 
Cardiac lesions No. (%) 
D- TGA 6 (10%) 
D- TGA, VSD,PS 6 (10%) 
Fallot's tetrology 12 (20%) 
Pulmonary atresia, VSD 3 (5%) 
VSD 12 (20%) 
Combined VSD& PDA 3 (5%) 
Patent ductus arterteiosus (PDA) 12 (20%) 
DORV, malposed vessels 3 (5%) 
A-V canal 3 (5%) 
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Table 2: Comparison between anthropometric measures of the studied patients and control groups (ANOVA). 
 
Variables 
Cyanotic 
Subgroup I 
N=30 
Acyanotic 
Subgroup II 
N=30 
Total patients 
group 
N=60 
Control 
group 
N=30 
SubgroupI 
versus 
SubgroupII 
Total patients 
versus control 
 
 
F 
 
 
P value 
 Mean ± SD Mean ± SD Mean ± SD Mean ± SD P value P value 
Age (months) 16.37 ± 16.93 25.07 ± 21.81 20.72 ± 19.68 21.38 ± 22.68 0.259 0.914 0.658 0.522 
Weight (kgs) 6.34 ± 2.37 8.32 ± 2.33 7.33 ± 2.52 10.0 ± 2.65 0.034 0.001** 9.415 <0.001** 
Height (cm) 66.33 ± 9.72 70.37 ± 7.46 68.35 ± 8.76 78.05 ± 10.08 0.239 0.001** 7.291 0.002** 
Occipitofrontal 
Circumference (cm) 
41.53 ± 3.86 44.33 ± 2.76 42.93 ± 3.59 46.4 ± 3.55 0.3 0.002** 8.614 0.001** 
Mid-arm circumference (cm) 11.43 ± 1.69 12.97 ± 1.27 12.2 ± 1.66 13.49 ± 0.9 0.2 0.003** 11.289 <0.001** 
Mid-chest circumference (cm) 43.27 ± 5.2 44.73 ± 3.42 44.0 ± 4.38 49.85 ± 3.31 0.32 <0.001** 13.375 <0.001** 
Weight for age percentile 13.1 ± 0.56 18.0 ± 13.1 14.66 ± 9.72 41.16 ± 15.09 0.013 <0.001** 56.971 <0.001** 
Height for age percentile 12.43 ± 2.83 12.95 ± 3.54 12.69 ± 3.16 50.99 ± 19.32 0.909 <0.001** 89.160 <0.001** 
Wt for ht percentile 15.87 ± 17.84 26.47 ± 22.0 21.17 ± 20.4 43.24 ± 23.57 0.018 0.001** 7.212 0.002** 
Weight for age z-score -3.29 ± 1.0 -2.21 ± 1.31 -2.75 ± 1.27 -0.25 ± 0.42 0.003 <0.001** 47.505 <0.001** 
Height for age z-score -3.16 ± 1.39 -2.49 ± 1.37 -2.83 ± 1.4 0.25 ± 0.55 0.107 <0.001** 46.612 <0.001** 
Wt for ht z- score -1.45 ± 0.97 -0.28 ± 1.09 -0.86 ± 1.17 -0.24 ± 0.65 0.001 0.036** 9.230 <0.001** 
 
*Significant difference at p<0.05, **highly significant difference at p<0.005. 
 
 
Highly significant differences between the 
cyanotic, acyanotic, and control groups as regards all 
anthropometric measures were demonstrated by 
ANOVA test in Table 2. The mean weight, height, 
weight and height for age, weight for height 
percentiles and z-scores, occipito-frontal, mid-arm, 
and mid chest circumferences of the studied patients 
group were statistically highly significant lower as 
compared to healthy controls (P<0.001 in all). The 
mean weight for age, weight for height percentiles and 
z-scores were statistically significant lower in cyanotic 
subgroup as compared to acyanotic subgroup 
(P<0.05).  
Thirty three (55%) of the patients were with 
severe malnutrition (WAZ score ≤−3), while twenty 
seven (45%) of the patients with moderate 
malnutrition. Wasting (low WHZ) was present in 36 
(60%) patients and was proportionately higher in 
cyanotic CHD (P = 0.001). 
ANOVA test revealed highly significant 
elevation of serum  levels of casein antibody, total iron 
binding capacity, and alkaline phoshatase activity 
compared to healthy controls (P<0.000 in all), 
whereas serum levels of calcium, iron and hemoglobin 
were highly significant decrease in patients as 
compared to healthy controls (P<0.000). There is no 
significant difference between patients' subgroups 
(P>0.05). Comparison of the laboratory findings of the 
studied patients and control groups by ANOVA test 
are shown in Table 3. 
 
 
Table 3: Comparison of the laboratory findings of the studied patients and control groups (ANOVA). 
 
Variables 
Cyanotic 
Subgroup I N=30 
Acyanotic 
Subgroup II 
N=30 
Total patients 
 
N=60 
Control 
group 
N=30 
SubgroupI 
versus 
SubgroupII 
Total 
patients 
versus 
controls 
 
 
F 
 
 
P value 
 Mean ± SD Mean ± SD Mean ± SD Mean ± SD P value P value 
Serum casein antibody (g/ml) 347.83 ± 249.6 350.16 ± 283.03 349.0 ± 262.2 92.2 ± 2.92 0.975 <0.001** 9.327 <0.001** 
Serum calcium (mg/dl)  8.45 ± 0.33 8.56 ± 0.52 8.5 ± 0.43 9.38 ± 0.29 0.471 <0.001** 31.357 <0.001** 
Serum alkaline phosphatase (U/mL) 336.53 ± 84.12 380.71 ± 110.56 358.62 ± 99.1 106.4 ± 14.38 0.12 <0.001** 66.702 <0.001** 
Serum iron (μg/dl)   39.0 ± 8.03 33.40 ± 6.10 36.2 ± 7.56 73.5 ± 8.75 0.056 <0.001** 138.22 <0.001** 
Serum TIBC (μg/dl) 410.0 ± 14.52 399.53 ± 37.54 404.77 ± 28.64 285.4 ± 27.4 0.312 <0.001** 109.28 <0.001** 
HB (gm/dl) 11.87 ± 1.8 11.54 ± 1.7 11.7 ± 1.72 13.05 ± 0.77 0.535 <0.001** 5.495 0.007** 
MCV (fl/red cell) 64.36 ± 10.94 65.86 ± 9.68 65.11 ± 10.18 78.4 ± 2.909 0.618 <0.001** 15.948 <0.001** 
MCHC (gm/dl) 23. 67 ± 5.90 20.67 ± 3.55 21.99 ± 26.6 26.6 ± 1.142 0.065 0.002** 10.507 <0.001** 
 
*Significant difference at p<0.05, **highly significant difference at p<0.005.  
Total iron capacity (TIBC), hemoglobin  (HB), mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC).  
 
Post hoc test revealed statistically highly 
significant elevation of the serum levels of casein IgE 
antibody, alkaline phoshatase activity, total iron 
binding capacity, and highly significant lower 
hemoglobin level, mean corpuscular volume, mean 
corpuscular hemoglobin concentration, serum calcium 
and iron levels of the cyanotic patients in subgroup I, 
and acyanotic patients in subgroup II as compared to 
control group (P<0.001 in all). There is no statistically 
significant difference between patients' subgroups. 
Comparison of the laboratory findings of the studied 
patients and control groups by Post hoc test are 
shown in Table 4.  
Patient's serum casein antibody level showed 
significant positive correlations with serum alkaline 
phosphatase activity, total iron binding capacity and 
significant negative correlations with the age at onset 
of symptoms, the weight, and height for age 
percentiles and z-scores, occipito-frontal, mid-arm, 
mid chest circumferences, mean corpuscular volume, 
mean corpuscular hemoglobin concentration, serum 
calcium, and iron levels. Correlations between age at 
onset of symptoms, all anthropometric measures, and 
laboratory measures versus serum casein antibody 
levels are shown in Table 5.  
On analyzing risk factors using odds ratio, 
gastrointestinal symptoms as abdominal pain, 
distension, vomiting, and diarrhea were found to be 
statistically significant strong predictors for high serum 
casein  antibody  levels  in  patients   with   CHD  with  
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Table 4:  Comparison of the laboratory findings of the studied 
patients and control groups (Post Hoc).  
 
Dependent Variables  Mean Difference P value 
Serum calcium 
Cyanotic /Acyanotic -0.10 0.471 
Cyanotic /Control -0.92** <0.001 
Acyanotic /Control -0.82** <0.001 
Serum ALP 
Cyanotic /Acyanotic -44.18 0.120 
Cyanotic /Control 230.13** <0.001 
Acyanotic /Control 274.31** <0.001 
Serum TIBC 
Cyanotic /Acyanotic 10.46 0.312 
Cyanotic /Control 124.6** <0.001 
Acyanotic /Control 114.13** <0.001 
Serum casein antibody 
Cyanotic /Acyanotic -2.3 -0.975 
Cyanotic /Control 255.6** 0.001 
Acyanotic/ Control 257.9** 0.001 
Serum iron  
Cyanotic /Acyanotic 5.6 0.056 
Cyanotic /Control -34.5** <0.001 
Acyanotic /Control -40.1** <0.001 
Hemoglobin 
Cyanotic /Acyanotic 0.32 0.535 
Cyanotic /Control -1.18
*
 0.020 
Acyanotic /Control -1.51** 0.003 
Mean corpacular volume 
Cyanotic /Acyanotic -1.5 0.618 
Cyanotic /Control -14.04** <0.001 
Acyanotic /Control -12.54** <0.001 
Mean corpacular 
hemoglobin 
concentration 
Cyanotic /Acyanotic 2.64 0.065 
Cyanotic /Control -3.29
*
 0.015 
Acyanotic/ Control -5.93** <0.001 
 
*Significant difference at p<0.05, **highly significant difference at p<0.005. Total iron 
capacity (TIBC), alkaline phosphatase (ALP). 
 
prediction of 95%. The low weight, and height for age 
percentiles and z-scores, occipito-frontal, mid arm, 
mid chest circumferences, levels of hemoglobin, mean 
corpuscular volume (MCV), mean corpuscular 
hemoglobin concentration (MCHC), serum levels of 
calcium and iron, and the high serum levels of total 
iron binding capacity and alkaline phoshatase activity 
were found to be statistically significant strong 
predictors for high serum casein antibody levels in 
children with CHD with prediction of 95% as shown in 
Table 6.  
Table 5: Correlations between age at onset of symptoms, all 
anthropometric measures, and laboratory measures versus 
serum casein antibody levels. 
Variables 
Occipito-
frontal 
Circum-
ference 
Mid-
arm 
circum-
ference 
Mid-
chest 
circum 
Weight 
for age 
percentile 
Height 
for age 
percentile 
Weight 
for age  
z-
score 
Height 
for 
age z 
score 
Serum 
casein  
antibody 
levels 
 
Pearson 
Correlation 
(r) 
-0.316* -0.449** -0.385** -0.501** -0.501** -0.503** -0.562** 
Sig. (2-
tailed) 
0.025 0.001 0.006 0.000 0.000 0.000 0.000 
Variables 
 
Age at 
Onset of 
symptoms 
Serum 
calcium 
Serum 
ALP 
Serum 
iron 
Serum 
TIBC 
MCV MCHC 
Serum 
casein  
antibody 
levels 
 
 
Pearson 
Correlation 
(r) 
-0.325* -0.499
**
 .489
**
 -0.477
**
 0.526
**
 -0.302
*
 -0.301
*
 
Sig. (2-
tailed) 
0.021 0.000 0.000 0.000 0.000 0.033 0.034 
 
*Significant difference at p<0.05, **highly significant difference at p<0.005. Total iron 
capacity (TIBC), Alkaline phosphatase (ALP), Mean corpuscular volume (MCV), Mean 
corpuscular hemoglobin concentration (MCHC). 
 
 
Predictors for high serum casein antibody 
levels in patients with CHD were low hemoglobin 
level, growth retardation, and high serum alkaline 
phosphatase activity (P <0.05 in all) by multiple 
regression analysis as shown in Table 7. 
 
Discussion  
Patients with CHD appear to have an 
increased prevalence of growth failure and 
malnutrition. Factors predictive of growth retardation 
and malnutrition in patients with congenital heart 
disease remain unclear [21]. Cow's milk allergy is an 
immunologically mediated adverse reaction to several 
allergenic proteins present in cow's milk. It is common 
in infants and very young children, but rarely develops 
after one year of age. The onset is closely related to 
the introduction of cow’s milk based infant formula 
[22]. 
Table 6: Univariate analysis between anthropometric 
measures, gastrointestinal symptoms, and laboratory 
measures versus serum casein antibody levels.  
   
 
     Covariates 
 
High 
serum 
Casein  
antibody 
 
Normal 
serum 
Casein 
antibody 
  
        Odd Ratio 
       (95 %C.I)         
 
 
 
P value 
 
% 
 
% 
Positive Gastrointestinal symptoms 
-Abdominal pain  
- Abdominal distension 
-Vomiting  
-Diarrhea 
-Rickets 
 
70.0% 
76.5% 
87.5%. 
82.4% 
92.9% 
 
30.0% 
23.5% 
12.5% 
17.6% 
7.1% 
 
1.08(0.24-4.79) 
104(10.59-1021)  
Cannot be calc.  
Cannot be calc. 
Cannot be calc. 
 
<0.001** 
<0.001** 
<0.001** 
<0.001** 
<0.001** 
Anthropometric measures 
-Weight for age percentile    <5 th 
- Height for age percentile <5 th     
- Weight for age z-score     <-2 z-score  
 - Height for age z-score   <-2 z-score      
-Mid arm circumference   <13.5 cm 
- Mid chest circumference   <49 cm 
 
48.1% 
52.0% 
52.6% 
52.4% 
33.3% 
40.6% 
 
51.9% 
48.0% 
47.4% 
47.6% 
66.7% 
59.4% 
 
20.43(2.4-173.89) 
26(3.03-222.93) 
7.5(1.88-29.91) 
9.53(2.19-41.47) 
1.8(0.5-6.43) 
11.63(1.37-98.53) 
 
0.001** 
<0.001** 
0.002** 
0.001** 
0.363 
0.008** 
Laboratory findings  
-Serum calcium (<9 mg/dl) 
-Serum alkaline phosphatase(<250  U/mL) 
-Serum iron (<50 μg/dl) 
-Serum total iron binding capacity(<380 μg/dl) 
- HB(<12gm/dl) 
- MCV(<80 fl/red cell) 
- MCHC(<25 (gm/dl) 
 
48.3% 
44.4% 
46.7% 
48.3% 
50.0% 
45.8% 
47.4% 
 
51.7% 
55.6% 
44.4% 
51.7% 
50.0% 
54.2 % 
52.6% 
 
Cannot be calc. 
8.4(1.63-43.18) 
Cannot be calc. 
Cannot be calc. 
3.75(0.95-14.82) 
6.49(1.53-27.56) 
4.68(1.26-17.42) 
 
<0.001** 
0.005** 
<0.001** 
0.000** 
0.052 
0.007** 
0.017* 
*Significant difference at p<0.05, **highly significant difference at p<0.005. Total iron 
capacity (TIBC), Alkaline phosphatase (ALP), Mean corpuscular volume (MCV), Mean 
corpuscular hemoglobin concentration (MCHC). 
 
To our best knowledge, there is no available 
research in the literature regarding the prevalence of 
cow's milk allergy among malnourished infants and 
children with congenital heart diseases. Therefore, our 
study is considered to be the first clinical study that 
measure antibody response to bovine casein through 
assaying serum casein antibody levels in 
malnourished children three years or younger with 
CHD in Egypt and examine its relationship with 
anthropometric measures, and gastrointestinal 
symptoms.   
Table 7: Multiple logistic regression analysis of factors 
associated with high serum casein antibody levels among the 
studied patients with congenital heart disease. 
Variables B S.E. Wald df Exp(B) Sig. 
Constant 32.08 15.82 4.112 1 8.5 0.043* 
Weight for age percentile -0.333 0.166 4.032 1 0.717 0.045* 
Height for age percentile 1.489 0.766 3.778 1 4.433 0.049* 
Serum alkaline 
phosphatase activity 
-0.021 0.009 5.465 1 0.979 0.019* 
Hemoglobin level -0.821 0.433 3.592 1 0.440 0.048* 
Variable(s) entered on step 1: *Significant difference at p<0.05, **highly significant 
difference at p<0.005. 
 
 
Our studied patients with CHD were 
diagnosed by clinical, echocardiographic and other 
routine tests. Based on the type of CHD, the patients 
were assigned to either an acyanotic or a cyanotic 
group. The present study showed statistically 
significant high levels of serum casein IgE antibodies 
among infants and children with congenital heart 
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diseases (cyanotic and acyanotic) on comparison with 
controls (P<0.000). Serum levels of casein antibodies 
showed significant negative correlation with the age at 
onset of symptoms of the studied patients. Statistically 
highly significant elevation of the serum levels of 
casein antibody was demonstrated in the cyanotic 
patients (P<0.001). This could be explained by the 
age at commencement of weaning in our study was 
significantly lower in cyanotic CHD as compared with 
acyanotic CHD (P<0.05).  
No statistical significant difference was found 
in the duration of breast feeding among cases and 
controls (P=0.87), and complementary feeds were 
introduced earlier in children with CHD as compared 
to controls (P<0.001). Elevation of serum levels of 
casein IgE antibodies were found in bottle fed infants 
as compared to breast fed infants (P<0.001). 
In the current study, the main typical 
symptoms of cow's milk allergy were abdominal pain, 
distension, vomiting, and diarrhea following intake of 
dairy products for infants. In a small number of infants, 
there is rash, which can spread all over the body, 
runny nose, sneezing and itchy watery eyes, 
coughing, choking, wheezing or difficulty breathing. 
On analyzing risk factors using odds ratio, 
gastrointestinal symptoms as abdominal pain, 
distension, vomiting, and diarrhea were found to be 
significantly strong predictors of high serum levels of 
casein antibody in the studied patients with CHD with 
prediction of 95%, (P<0.001). This is in agreement 
with the study conducted by Vandenplas et al. [6], and 
Host et al. [23] who reported a relation between 
positive history of gastrointestinal symptoms and high 
levels of serum casein IgE antibodies. 
Growth often varies according to the type and 
severity of heart disease. Progressive decline in 
nutritional status is linked with deteriorating cardiac 
function, morbidity and mortality. Acute malnutrition in 
the form of wasting is attributable to acute events, 
while stunting (chronic malnutrition) is usually 
associated with prolonged suboptimal dietary intake 
[24]. In the present study, the mean body weight, 
height, weight and height for age, weight for height 
percentiles and z-scores, occipito-frontal, mid-arm, 
and mid chest circumferences of the studied patients 
group were statistically highly significant lower as 
compared to controls (P<0.001). The mean weight for 
age, weight for height percentiles and z-scores of the 
studied patients group were statistically significant 
lower in cyanotic group as compared to acyanotic 
group (P<0.05). Highly significant differences between 
the cyanotic, acyanotic, and control groups as regards 
all anthropometric measures were demonstrated 
(P<0.001). 
In our present study, severe malnutrition was 
found in thirty three (55%) of the studied infants and 
young children, while, moderate malnutrition was 
shown in twenty seven of them (45%). Wasting (low 
WHZ) was proportionately higher in cyanotic CHD 
(P=0.001). The low body weight and height for age 
percentiles and z-scores, occipito-frontal, mid-arm, 
mid-chest circumferences were found to be 
statistically significant strong predictors of high serum 
casein antibody levels in infants and young children 
with CHD with prediction of 95%. Our results are in 
conformity with WHO reports, who reported that, 
wasting was the most prevalent type of malnutrition 
rather than underweight and stunting in pediatric 
patients with CHD [13]. Previous reports on the 
patterns of malnutrition in acyanotic and cyanotic CHD 
vary widely [24-26]. In South India, Vaidyanathan et 
al. [25, 26] reported a higher prevalence of 
underweight (59.0%) and wasting (55.9%) with 
wasting being more prevalent than stunting in children 
with CHD, as in our study. Weintraub et al. [27] 
reported that both wasting and stunting were more 
common in cyanotic CHD than in acyanotic CHD. 
However, Varan et al. [28] noted that most infants 
(88%) with cyanotic CHD without pulmonary 
hypertension had mild malnutrition and that stunting 
was more common than wasting in these patients.  
Anemia is an important risk factor for 
morbidity and mortality among infants and young 
children with cyanotic and acyanotic congenital heart 
disease [29], in the absence of vitamin or mineral 
deficiency, hemolytic or other definable causes [30]. It 
is commonly unrecognized because it is often 
asymptomatic or exhibits largely nonspecific 
symptoms. Acyanotic CHD heart failure may occur 
and worsen by anemia as comorbidity [31].  
Amoozgar et al. [32] reported that more than 
one third of the patients with CHD had iron deficiency 
anemia. In our present study, hypochromic microcytic 
anemia (low levels of hemoglobin, mean corpuscular 
volume, and mean corpuscular hemoglobin) 
suggestive of iron deficiency anemia was found in 90 
% of all patients. Highly significant elevation of serum 
levels of total iron binding capacity, and highly 
significant lower levels of hemoglobin, mean 
corpuscular volume (MCV), mean corpuscular 
hemoglobin mean corpuscular hemoglobin 
concentration (MCHC), and iron of the cyanotic 
patients, and acyanotic patients were demonstrated 
as compared to control groups (P<0.001 in all). No 
statistical significant difference was found between 
patients' subgroups. Serum levels of casein antibodies 
showed significant positive correlations with total iron 
binding capacity of the studied patients and significant 
negative correlation with (MCV), (MCHC), and serum 
iron levels. On analyzing risk factors using odds ratio, 
the serum iron, total iron binding capacity, (MCV), and 
(MCHC) were found to be significantly strong 
predictors of high serum casein IgE antibody levels 
with prediction of 95%. 
In light of the current results, patients showed 
statistically highly significant increase in serum level of 
alkaline phoshatase activity with respect to healthy 
controls (P<0.001 in all). However, serum calcium 
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levels showed highly significant decrease in children 
with CHD relative to healthy controls (P<0.001). There 
was no significant difference between patients' 
subgroups. Serum levels of casein antibodies showed 
significant positive correlations with serum alkaline 
phosphatase activity of the studied patients and 
significant negative correlations with serum calcium 
levels. On analyzing risk factors using odds ratio, the 
serum level of calcium, alkaline phoshatase activity 
and rachitic manifestations were found to be 
significantly strong predictors of high serum casein 
IgE antibody levels with prediction of 95%. 
In view of the present data, growth retardation 
(severe wasting, and stunting), anemia, and high 
serum alkaline phosphatase activity were significantly 
strong predictors of high serum casein IgE antibody 
levels (P<0.001). 
In conclusion, the present study showed high 
levels of serum casein IgE antibodies among infants 
and children with congenital heart diseases that play a 
significant role in the pathogenesis of malnutrition in 
patients suffering from cow's milk protein allergy. In 
children with CHD, severe wasting and stunting in 
association with rickets and iron deficiency anemia 
are strong predictors of high serum casein IgE 
antibody levels. Encouragement of breast feeding 
within the first six months of life, and the avoidance of 
cow's milk consumption early in life could prevent the 
development of antibody response to bovine casein, 
and its subsequent malnutrition. 
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